These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 207298)
1. Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts. Looney WB; Macleod MS; Hopkins HA Br J Cancer; 1978 May; 37(5):841-8. PubMed ID: 207298 [TBL] [Abstract][Full Text] [Related]
2. Solid tumor models for the assessment of different treatment modalities: VIII. The scheduling of treatment for a chemotherapeutically resistant experimental solid tumor. Looney WB; Hopkins HA; MacLeod MS Cancer; 1979 Apr; 43(4):1201-10. PubMed ID: 445323 [TBL] [Abstract][Full Text] [Related]
3. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration. Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899 [TBL] [Abstract][Full Text] [Related]
4. Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A. Kovacs CJ; Hopkins HA; Simon RM; Looney WB Br J Cancer; 1975 Jul; 32(1):42-50. PubMed ID: 169869 [TBL] [Abstract][Full Text] [Related]
5. Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil. Looney WB; Schaffner JG; Trefil JS; Kovacs CJ; Hopkins HA Br J Cancer; 1976 Sep; 34(3):254-61. PubMed ID: 184808 [TBL] [Abstract][Full Text] [Related]
6. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor. Myers CE; Young RC; Chabner BA Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826 [TBL] [Abstract][Full Text] [Related]
7. Response kinetics of host and experimental solid tumour after adriamycin. Hopkins HA; Looney WB; Teja K; Hobson AS; MacLeod MS Br J Cancer; 1978 Jun; 37(6):1006-14. PubMed ID: 209806 [TBL] [Abstract][Full Text] [Related]
8. Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation. Looney WB; Hopkins HA; Grover WH; Macleod MS; Ritenour ER; Hobson AS Cancer; 1980 Jun; 45(11):2793-804. PubMed ID: 7379010 [TBL] [Abstract][Full Text] [Related]
9. A study of trace and minor elements in the solid tumor model 3924A hepatoma before and after treatment with t-fluorouracil. Brookhart W; Allen R; Looney W; Hopkins H; Kovacs C; Morris H Life Sci; 1975 Jul; 17(2):233-40. PubMed ID: 169448 [No Abstract] [Full Text] [Related]
10. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours. Shibamoto Y; Murata R; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Shibata T; Oya N; Takahashi M Br J Cancer; 1996 Dec; 74(11):1709-13. PubMed ID: 8956782 [TBL] [Abstract][Full Text] [Related]
11. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma. Cao S; Frank C; Rustum YM J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234 [TBL] [Abstract][Full Text] [Related]
12. Polyamine depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924A hepatomas after 5-fluorouracil administration. Russell DH; Looney WB; Kovacs CJ; Hopkins HA; Marton LJ; LeGendre SM; Morris HP Cancer Res; 1974 Sep; 34(9):2382-5. PubMed ID: 4367291 [No Abstract] [Full Text] [Related]
13. [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil]. Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K Gan To Kagaku Ryoho; 1982 Oct; 9(10):1797-800. PubMed ID: 6307175 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model. Sadahiro S; Suzuki T; Ishikawa K; Tanaka Y; Masuda T; Nakamura T; Yasuda S; Makuuchi H; Murayama C Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056 [TBL] [Abstract][Full Text] [Related]
15. Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen. Makino M; Shoji H; Takemoto D; Honboh T; Nakamura S; Kurayoshi K; Kaibara N Cancer Chemother Pharmacol; 2001 Nov; 48(5):370-4. PubMed ID: 11761454 [TBL] [Abstract][Full Text] [Related]
16. Solid tumor models for the assessment of different treatment modalities: XXIII. A new approach to the more effective utilization of radiotherapy alternated with chemotherapy. Looney WB; Hopkins HA; Carter WH Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2105-17. PubMed ID: 4066443 [TBL] [Abstract][Full Text] [Related]
17. Synchronization of host and tumor responses for sequential therapy in experimental solid tumors. Hopkins HA; Looney WB Antibiot Chemother (1971); 1978; 23():135-47. PubMed ID: 206197 [No Abstract] [Full Text] [Related]
18. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo. Lemaire LP; McSheehy PM; Griffiths JR Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055 [TBL] [Abstract][Full Text] [Related]
20. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model. Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]